Novanta Inc

Novanta Inc

NOVT

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.53B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novanta IncNovanta Inc116.9-4%6.30.2
$165.00

Target Price by Analysts

9% upsideNovanta Target Price DetailsTarget Price
$32.47

Current Fair Value

78.5% downside

Overvalued by 78.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.53 Billion
Enterprise Value$5.43 Billion
Dividend Yield$- (-)
Earnings per Share$1.47
Beta1.68
Outstanding Shares40,425,000

Return

Return on Equity4.10%ROE
Return on Assets2.99%
Return on Invested Capital7.09%

Valuation & Multiples

P/E Ratio116.87P/E Ratio
PEG-22738.34PEG
Price to Sales6.31Price to Sales
Price to Book Ratio4.73Price to Book Ratio
Enterprise Value to Revenue5.41
Enterprise Value to EBIT48.58
Enterprise Value to Net Income101
Total Debt to Enterprise0.05
Debt to Equity0.22Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$0.78
Average shareholder expectation
Revenue Estimate
$253.51 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$0.83
Average shareholder expectation
Revenue Estimate
$262.30 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio3.9945 432.40%
Total Calls109,300 709.63%
Total Puts436,600 288.78%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %110.69% 2.14%
Total Invested$4.78B 3.64%
Investors Holding341 8.00%

ESG Score

No data

About Novanta Inc

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the official revenue estimates and technical analysis for all tax bills, directly influencing corporate tax structures, capital investment credits, and the overall tax burden on industries like manufacturing, critically impacting Novanta's financial outlook.

Finance

This powerful committee controls taxation, trade, and entitlement spending. Its decisions on corporate tax policy, tariffs, and Medicare pricing can directly impact Novanta's profitability, global supply chain, and demand from its medical OEM customers.

Appropriations

This committee directly allocates discretionary federal spending, determining the precise cash flow for defense programs, scientific research, and infrastructure projects that could utilize Novanta's components and directly impact its potential order books.

Health, Education, Labor, and Pensions

This committee directly impacts Novanta's medical OEM customers through FDA regulations on medical devices and influences medical R&D via NIH. Its oversight of labor laws also directly affects Novanta's manufacturing costs.

Armed Services

Novanta's precision motion, photonics, and vision technologies are highly relevant to defense applications and emerging military technologies, making this committee's funding authorizations directly impactful on potential demand from defense contractors.

Commerce, Science, and Transportation

This committee has broad oversight over interstate commerce, science, and industries like aerospace and telecommunications, which are key markets for Novanta's precision motion, vision, and photonics technologies. It also influences R&D.